Ohya S, Matsui M, Kajikuri J. Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease. JGLD [Internet]. 2020 Dec. 12 [cited 2026 Oct. 9];29(4):487-9. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/3234